8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Stroke in 1 studies
8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chua, P | 1 |
| Lim, WK | 1 |
1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Stroke
| Article | Year |
|---|---|
Optimisation of a PC12 cell-based in vitro stroke model for screening neuroprotective agents.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Apoptosis; Cell Differentiation; Cell Hypoxia; Cell | 2021 |